RNA medicines can target any gene or protein in humans and so can be used to treat diseases that cannot be treated by conventional drugs such as small molecules and biologics.
Our bodies and cells are made up of many different proteins. Diseases occur when genes and proteins inside our bodies malfunction. DNA contains the genetic code needed for cells to make proteins. Various types of RNA, including messenger RNA (mRNA), small interfering RNA (siRNA) and microRNA, work together to control how the genes contained in our DNA are translated into proteins.
Arcturus’ proprietary UNA Oligomer™ and LUNAR™ delivery technologies can be used to make all classes of RNA medicines safe and effective.
NOVA scienceNOW : 8 – RNAi – click to view
August 9, 2017
Arcturus Therapeutics in the list of Cystic Fibrosis Key Companies
July 13, 2017
Arcturus Therapeutics Inc. is Listed in the Key Players List; Involved in Non Alcoholic Steatohepatitis Pipeline (NASH)
July 7, 2017
The Korea Herald News on Arcturus Therapeutics Inc.